Lördag 14 Mars | 22:33:47 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2027-03-05 08:00 Bokslutskommuniké 2026
2026-11-28 17:35 Kvartalsrapport 2026-Q3
2026-08-28 17:35 Kvartalsrapport 2026-Q2
2026-05-29 17:35 Kvartalsrapport 2026-Q1
2026-05-21 N/A Årsstämma
2026-03-27 08:00 Bokslutskommuniké 2025
2025-12-18 - Extra Bolagsstämma 2025
2025-11-27 - Kvartalsrapport 2025-Q3
2025-08-28 - Kvartalsrapport 2025-Q2
2025-05-29 - Kvartalsrapport 2025-Q1
2025-05-23 - X-dag ordinarie utdelning OPTI 0.00 SEK
2025-05-22 - Årsstämma
2025-03-28 - Bokslutskommuniké 2024
2024-11-06 - Extra Bolagsstämma 2024
2024-10-18 - Kvartalsrapport 2024-Q3
2024-08-29 - Kvartalsrapport 2024-Q2
2024-05-31 - Kvartalsrapport 2024-Q1
2024-05-23 - Årsstämma
2024-05-17 - X-dag ordinarie utdelning OPTI 0.00 SEK
2024-03-28 - Bokslutskommuniké 2023
2024-02-27 - Bokslutskommuniké 2023
2023-11-28 - Kvartalsrapport 2023-Q3
2023-10-05 - Extra Bolagsstämma 2023
2023-08-29 - Kvartalsrapport 2023-Q2
2023-05-05 - Kvartalsrapport 2023-Q1
2023-03-09 - X-dag ordinarie utdelning OPTI 0.00 SEK
2023-03-08 - Årsstämma
2023-02-14 - Bokslutskommuniké 2022
2022-11-23 - Extra Bolagsstämma 2022
2022-11-15 - Kvartalsrapport 2022-Q3
2022-08-16 - Kvartalsrapport 2022-Q2
2022-05-27 - X-dag ordinarie utdelning OPTI 0.00 SEK
2022-05-25 - Årsstämma
2022-05-06 - Kvartalsrapport 2022-Q1
2022-02-09 - Bokslutskommuniké 2021
2021-11-16 - Kvartalsrapport 2021-Q3
2021-08-31 - Kvartalsrapport 2021-Q2
2021-06-28 - Årsstämma
2021-05-28 - Kvartalsrapport 2021-Q1
2021-05-14 - X-dag ordinarie utdelning OPTI 0.00 SEK
2021-03-05 - Extra Bolagsstämma 2021
2021-02-16 - Bokslutskommuniké 2020
2020-11-06 - Kvartalsrapport 2020-Q3
2020-08-18 - Kvartalsrapport 2020-Q2
2020-05-15 - X-dag ordinarie utdelning OPTI 0.00 SEK
2020-05-14 - Årsstämma
2020-05-05 - Kvartalsrapport 2020-Q1
2020-02-14 - Bokslutskommuniké 2019
2019-11-28 - Kvartalsrapport 2019-Q3
2019-08-29 - Kvartalsrapport 2019-Q2
2019-08-22 - Extra Bolagsstämma 2019
2019-05-23 - Kvartalsrapport 2019-Q1
2019-04-12 - X-dag ordinarie utdelning OPTI 0.00 SEK
2019-04-11 - Årsstämma
2019-02-14 - Bokslutskommuniké 2018
2018-11-29 - Kvartalsrapport 2018-Q3
2018-08-29 - Kvartalsrapport 2018-Q2
2018-05-24 - Kvartalsrapport 2018-Q1
2018-04-25 - X-dag ordinarie utdelning OPTI 0.00 SEK
2018-04-24 - Årsstämma
2018-02-15 - Bokslutskommuniké 2017
2017-11-29 - Kvartalsrapport 2017-Q3
2017-08-29 - Kvartalsrapport 2017-Q2
2017-05-30 - Kvartalsrapport 2017-Q1
2017-03-15 - X-dag ordinarie utdelning OPTI 0.00 SEK
2017-03-14 - Årsstämma
2017-02-17 - Bokslutskommuniké 2016
2016-11-24 - Kvartalsrapport 2016-Q3
2016-08-26 - Kvartalsrapport 2016-Q2
2016-05-26 - Kvartalsrapport 2016-Q1
2016-04-29 - X-dag ordinarie utdelning OPTI 0.00 SEK
2016-04-26 - Årsstämma
2016-02-25 - Bokslutskommuniké 2015
2015-11-26 - Kvartalsrapport 2015-Q3
2015-08-27 - Kvartalsrapport 2015-Q2
2015-05-28 - Kvartalsrapport 2015-Q1
2015-04-29 - X-dag ordinarie utdelning OPTI 0.00 SEK
2015-04-28 - Årsstämma
2015-02-26 - Bokslutskommuniké 2014
2014-11-26 - Kvartalsrapport 2014-Q3
2014-11-17 - Extra Bolagsstämma 2014
2014-08-29 - Kvartalsrapport 2014-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorMaterial
IndustriForskning & Utveckling
OptiCept Technologies förser livsmedels-och växtindustrin med teknologiska lösningar som används för att öka hållbarheten för diverse råvaror. Bolaget arbetar med biologiska processer som ger en ökad extraktion ur råvaran, minskat avfall samt bibehållen smak, doft, färg, näringsinnehåll. Bolaget har en patenterad teknologi inom PEF (pulsed electric field) och VI (Vacuum Infusion). Bolaget säljer sina produkter på en global nivå. Huvudkontoret ligger i Lund.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-03-12 11:30:00

In the coming days, we will further elaborate on and explain the company’s view of the agreement and the future.

As presented on March 8, OptiCept Technologies AB (publ) (“OptiCept”) has entered into a global commercialization agreement with FPS Food Process Solutions (“FPS”), one of the world’s leading suppliers of food processing equipment. The agreement means that OptiCept may receive up to approximately SEK 820 million in license revenues over 20 years, provided the agreement is not terminated. The agreement guarantees revenue of approximately SEK 150 million during the first five years.

Through this agreement, OptiCept establishes a new business model in which the company’s technology is commercialized globally via an industrial partner, while OptiCept retains the commercial upside through profit sharing.

Together with a comprehensive efficiency program, the conversion of loans into shares, and capital-releasing measures, the company strengthens its balance sheet and creates the conditions for positive results already in the second half of 2026.

“This is a transformative agreement for OptiCept. Through the collaboration with FPS, our technology immediately gains access to a global industrial platform with established sales and production capacity. At the same time, we are creating a more capital-efficient business model with recurring license revenues and significant upside through profit sharing. Overall, this strengthens our financial position and creates a clear path toward profitable growth,” says Ulf Hagman, Chairman of the Board.

Global Commercialization via an Industrial Partner

Through the agreement, the collaboration is expanded and from April 1, 2026, FPS will receive a global exclusive license to manufacture and commercialize OptiCept’s PEF systems within defined food segments, including:

  • vegetable oils
  • fruit and vegetable juices
  • wine

and previously:

  • potatoes
  • drying of vegetables and fruit

FPS will simultaneously assume responsibility for global commercialization, including:

  • manufacturing
  • sales
  • distribution
  • installation
  • service

Through this structure, OptiCept can scale the technology globally via an established industrial partner without having to build its own capital-intensive organization around the world.

OptiCept retains all intellectual property rights to the technology and will going forward focus on:

  • technology development
  • innovation
  • further development of the PEF platform

More information will be provided in an upcoming press release.

Stable and Growing Revenue Model

The agreement includes recurring fixed license revenues to OptiCept:

  • EUR 230,000 per month in 2026
  • EUR 250,000 per month during 2027–2031
  • EUR 350,000 per month from 2032

In addition to the fixed license revenues, OptiCept will also receive profit sharing from FPS’s commercialization of the technology.

The profit-sharing model means that OptiCept will receive 35–50 percent of the gross profit, without having to bear costs for production, inventory, or a global sales organization. When profit sharing is paid out, previously paid license fees will be deducted.

This structure allows OptiCept to retain the commercial upside while significantly reducing financial risk.

At the same time, FPS has set ambitious commercial targets for the market launch and possesses both the production capacity and global sales organization to scale sales much faster than OptiCept could have done on its own.

The agreement initially runs until 2046, but may be terminated every five years.

For Further Information, Please Contact

OptiCept Technologies AB (publ)
Ulf Hagman, Chairman of the Board
Phone: +46 73 363 63 80
Email: ulf.hagman@opticept.se